Amylyx Pharmaceuticals, Inc. ($AMLX)
Filing Information
| Accession Number | 0001193125-26-301996 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 13, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
30,000
Total Value
$538,867.50
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Legal Officer | Common Stock | โ | Jul 9, 2026 | Sale | 15,000 | $18.32 | $274,746.00 | 194,090 | Direct | โ | View Details | |
Chief Legal Officer | Common Stock | โ | Jul 10, 2026 | Sale | 15,000 | $17.61 | $264,121.50 | 179,090 | Direct | โ | View Details |